Fibromyalgia syndrome: epidemiology, diagnosis and treatment
MetadataShow full item record
CitationKoçyiğit, B. F., Akyol, A. (2022). Fibromyalgia syndrome: epidemiology, diagnosis and treatment. Reumatologia: Cilt, 60, s. 413-421.
Fibromyalgia syndrome (FMS) profoundly impacts patients’ quality of life with its symptoms and clinical signs. Fibromyalgia syndrome impairs daily living activities, reduces work efficiency and raises health-related costs. Although the prevalence rates vary depending on geographical location and diagnostic criteria, it is a common disorder worldwide. Females have a higher prevalence of fibromyalgia syndrome, with varied rates, and there is an increase in prevalence rates with age. Although its etiopathogenesis has not been fully elucidated, various hypotheses have been proposed that central sensitization is at the core of the process. Fibromyalgia syndrome diagnostic approaches have advanced significantly over time, moving away from pain assessments alone and emphasizing multiple clinical signs of FMS. This condition has raised physicians’ and researchers’ awareness of non-pain symptoms. Considering the complicated etiopathogenesis of fibromyalgia syndrome, diverse pathways connected with symptoms, and multiple clinical presentations, it becomes clear that drug and non-drug treatments should be chosen in combination. © 2022 Termedia Publishing House Ltd.. All rights reserved.